Company Interview / Hit IQ raises funds to take concussion tech global

Key points:

HIQ (ASX:HIQ) raises $250,000 to support commercialisation of concussion management technology Technology targets parents and amateur athletes with real-time impact data and telehealth connection Strategic move from elite sports to direct-to-consumer sales, with rapid global uptake Competitive edge attributed to app-based real-time data unavailable from other products

Earl Eddings of HIQ details the latest step in the company's mission to commercialise innovative concussion management technology, following a $250,000 capital placement. Eddings outlines how HIQ’s technology—integrated into Shock Doctor mouthguards—utilises multiple accelerometers to transmit real-time head impact data to a companion app, enabling immediate care through telehealth services for athletes across Australia. The company has recently pivoted from serving elite sports to targeting everyday consumers, asserting this segment represents a larger addressable market.

According to Eddings, HIQ (ASX:HIQ) stands out in a competitive environment, with its platform providing unique app-based data feedback compared to similar offerings. Eddings claims the recent consumer-facing shift has already yielded global traction, with new orders from the US and UK. HIQ’s funding boost, supported by strategic investors and a research and development loan, extends its operational runway to further grow its direct-to-consumer sales pipeline.

Reflecting on the rationale for investment, Eddings attributes the company’s renewed focus and leadership changes as key advantages. Eddings states HIQ's solution is well-positioned to address the growing concussion issue, emphasising emerging opportunities in the female sports market, where HIQ's data suggests an elevated need for such technology.